Legal analysis: Sanming medical reform in the adherence to the "government-led" premise, the establishment of a "medicine, health insurance, medical" three medical reform path.... The path of health care reform in accordance with the change of government, medicine, health insurance, medical path is divided into four steps to systematically carry out, known as the "cage for birds" four initiatives.
Legal basis: "on the further popularization of Fujian Province and Sanming City to deepen the experience of medical and health system reform notice" (two) to deepen the medical, medical insurance, pharmaceutical "three medical" linkage reform. Sanming City, in accordance with the idea of vacating the cage and exchanging birds and the path of vacating space, adjusting structure and ensuring convergence, deepens the "three medical" linkage reform, implements joint price-limiting procurement of medicines and consumables, and, in accordance with the principles of total amount control, structural adjustment, ascending and descending, and gradually put in place, focuses on using the vacated space for timely and corresponding adjustment of medical service prices, establishing a dynamic adjustment mechanism, and ensuring that the masses benefit from the reform. medical service prices, establish a dynamic adjustment mechanism, optimize the revenue structure of hospitals, and establish a new mechanism for the operation of public welfare. in 2018, the proportion of medical service revenue (excluding revenue from drugs, consumables, inspections, and laboratory tests, hereinafter the same) of public hospitals at the second level and above in Sanming City reached 42% of the medical revenue. Fujian Province comprehensively followed up on the pilot centralized procurement and use of drugs organized by the State, implemented sunshine procurement of medical consumables, and promptly adjusted medical service prices accordingly. The Fujian Provincial Medical Electronic Settlement Center realizes the direct payment and settlement of the medical insurance fund to the pharmaceutical enterprises.